Effect of cisplatin chemotherapy on extracortical tissue formation in canine diaphyseal segmental replacement

Journal of Orthopaedic Research

Volumn 15, Issue 5, 1997, Pages 773-780

  Young, D R ^a   Shih, L Y ^a   Rock, M G ^a   Frassica, F J ^a   Virolainen, P ^a   Chao, E Y S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOMECHANICS; DRUG THERAPY; FRACTURE FIXATION; GRAFTS; GROWTH KINETICS; INTERFACES (MATERIALS); JOINTS (ANATOMY); PROSTHETICS;

CANINE DIAPHYSEAL SEGMENTAL REPLACEMENT; CISPLATIN CHEMOTHERAPY; EXTRACORTICAL TISSUE;

TISSUE;

ALLOY; ALUMINUM; CISPLATIN; TITANIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DEFECT; BONE PROSTHESIS; BONE TUMOR; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOG; FEMUR; HISTOLOGY; IMPLANT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OSTEOLYSIS; OSTEOSARCOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL;

EID: 0031231623     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100150521     Document Type: Article

References (34)

1. 1 Aho AJ, Ekfors T, Dean PB, Aro HT, Ahonen A, Nikkanen V: Incorporation and clinical results of large allografts of the extremities and pelvis. Clin Orthop 307: 200–213, 1994
2. 2 Amsel S, Dell ES: Response of the preosteoblast and stem cell of rat bone marrow to a lethal dose of x‐irradiation or cyclophosphamide. Cell Tissue Kinet 4: 255–261, 1971
3. 3 Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei P, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C: Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72: 3227–3238, 1993
4. 4 Barth E, Roenningen H, Solheim LF, Saethren B: Effect of cisplatin on bone ingrowth into porous liber titanium. Int J Oral Maxillofac Imp 1: 123–127, 1986
5. 5 Burchardt H, Glowczeswski FP, Enneking WF: The effect of adriamycin and methotrexate on the repair of segmental cortical autografts in dogs. J Bone Joint Surg [Am] 65: 103–108, 1983
6. 6 Chao EYS, Coventry MB: Fracture of the femoral component after total hip replacement: an analysis of fifty‐eight cases. J Bone Joint Surg [Am] 63: 1078–1094, 1981
7. 7 Chao EYS, Sim FH: Composite fixation of salvage prostheses for the hip and knee. Clin Orthop 276: 91–101, 1992
8. 8 Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R: Effects of chemotherapeutic agents on bone. Part I: Short‐term methoterapeutic (adriamycin) treatment in a rat model. J. Bone Joint surg [Am] 66: 602–607, 1984
9. 9 Griffiths HJ, Anderson JR, Thompson RC, Admunson P, Detlie T: Radiographic evaluation of the complications of long bone allografts. Skeletal Radiol 24: 283–286, 1995
10. 10 Gruen TA, McNiece GM, Amstutz HC: Modes of failure of cemented stem‐type femoral components: a radiographic analysis of loosening. Clin Orthop 141: 17–27, 1979
11. 11 Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carrascc H, Wallace S, Murray J, Robertson R: Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10‐year experience. J Clin Oncol 8: 1988–1997, 1990
12. 12 Jaffe N, Patel SR, Benjamin RS: Chemotherapy in osteosarcoma: basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am 9: 825–840, 1995
13. 13 Khoo DBA: The effect of chemotherapy on soft tissue and bone healing in the rabbit model. Ann Acad Med Singapore 21: 217–221, 1992
14. 14 Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tom‐ford WW: Long‐term results of allograft replacement in the management of bone tumors. Clin Orthop 324: 86–97, 1996
15. 15 May KP, West SG, McDermont MT, Huffer WE: The effect of low‐dose methotrexate on bone metabolism and histomor‐phometry in rats. Arthritis Rheum 37: 201–206, 1994
16. 16 McDonald DJ, Fitzgerald RH Jr, Chao EYS: The enhancement of fixation of a porous‐coated femoral component by autograft and allograft in the dog. J Bone Joint Surg [Am] 70: 728–737, 1988
17. 17 McManus PM, Weiss L: Busulfan‐induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies. Blood 64: 1036–1041, 1984
18. 18 Mohler CG, Callaghan JJ, Collis DK, Johnston RC: Early loosening of the femoral component at the cement‐prosthesis interface after total hip replacement. J Bone Joint Surg [Am] 77: 1315–1322, 1995
19. 19 Nilsson OS, Bauer HC. Bronstrom L‐Å: Comparison of the effects of adriamycin and methotrexate on orthotopic and induced heterotopic bone in rats. J Orthop Res 8: 199–204, 1990
20. 20 Okaca Y, Suka T, Sim FH, Gorski JP, Chao EYS: Comparison r f replacement prostheses for segmental defects of bone. J Bone Joint Surg [Am] 70: 160–172, 1988
21. 21 Pelker RR, Friedlaender GE, Panjabi MM, Hausman M, Doganis AC, McKay J: Chemotherapy‐induced alterations in the biomechanics of rat bone. J Orthop Res 3: 91–95, 1985
22. 22 Rivero DP, Fox J, Skipor AK, Urban RM, Galante JO: Calcium phosphate‐coated porous titanium implants for enhanced skeletal fixation. J Biomed Mater Res 22: 191–201, 1988
23. 23 Rønningen H, Solheim LF, Langeland N: Bone formation enhanced by induction: bone growth in titanium implants in rats. Acta Orthop Scand 56: 67–71, 1985
24. 24 Rosen G: Preoperative (neoadjuvant) chemotherapy for os‐teogenic sarcoma: a ten year experience. Orthopedics 8: 659–664, 1987
25. 25 Schlotthauer CF, Janes JM: The time of closure of the lower femoral epiphyses and upper tibial epiphyses in the dog as determined by roentgenogram. Am J Vet Res 13: 90, 1952
26. 26 Silverton C, Rosenberg AO, Barden RM, Sheinkop MB, Galante JO: The prosthesis‐bone interface adjacent to tibial components inserted without cement: clinical and radiographic follow‐up at nine to twelve years. J Bone Joint Surg [Am] 78: 340–347, 1996
27. 27 Sim FH, Bowman WE Jr, Wilkins RM, Chao EYS: Limb salvage in primary malignant bone tumors. Orthopedics 8: 574–581, 1985
28. 28 Sim FH, Beauchamp CP, Chao EYS: Reconstruction of mus‐culoskeletal defects about the knee for tumor. Clin Orthop 221: 188–201, 1987
29. 29 Somriier‐Tsilenis E, Sauer HD, Kruse HP: Delaying effect of cyclophosamide on bone fracture healing chemical analyses of rat femora. Arch Orthop Trauma Surg 101: 89–93, 1983
30. 30 Spivak JM, Ricci JL, Blumenthal NC, Alexander H: A new canine model to evaluate the biological response of intra medullary bone to implant materials and surfaces. Biomed Mater Res 24: 1121–1149, 1990
31. 31 Velez‐Yanguas MC, Warrier RP: The evolution of chemothct apeutic agents for the treatment of pediatric musculoskeletal malignancies. Orthop Clin North Am 27: 545–549, 1996
32. 32 Wanebo HJ, Glicksman AS, Landman C, Slotman G, Dooliule C, Clark J, Koness RJ: Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control in patients with advances head and neck cancer. Am J Surg 170: 512–516. 1995
33. 33 Ward WG, Johnston KS, Dorey FJ, Eckurdt JJ: Extramedull ary porous coating to prevent diaphyseal osteolysis and radiolucent lines around proximal tibial replacements: a preliminary report. J Bone Joint Surg [Am] 75: 976–987, 1993
34. 34 Zart DJ, Miya L, Wolff DA, Makely JT, Stevenson S: The effects of cisplatin on the incorporation of fresh syngencic and frozen allogeneic cortical bone grafts. J Orthop Res 11: 240–249, 1993